The Institute of Molecular Biology has the institutional mission of meeting the demands for improvements in Health with excellence and priority,generating knowledge and production of inputs to primarily serve the SUS. The institute develops products that enable diagnoses of socially and financially costly diseases for the national health system. This is possible because of the proximity of the Institute with Oswaldo Cruz Foundation (Fiocruz) and other national and international research and development centers, funding agencies, and reference hospitals.
In IBMP, technological development seeks to technologically dominate areas necessary to obtain products for in-vitro diagnosis. Recently, the Institute began to act in order to obtain and apply therapeutic molecules for chronic degenerative diseases, tissue regeneration, and aesthetics.